Details

NameSymbolSector
COHANCE LIFESCIENCES LIMITEDCOHANCEPharmaceuticals
Open
876.95
High
879.95
Low
868.85
Close
875.7
Volume
222399
Exchange
nse
Time
03-Oct-2025

Outlook

Score:  

2.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Cohance Lifesciences is  
Homing Pigeon
Estimated Stoploss of Cohance Lifesciences is ₹  
865.75
Cohance Lifesciences has a  
Bullishℹ
 pattern. 
Formation of  
Homing Pigeon
 candle pattern indicates Cohance Lifesciences has chances of  
Reversalℹ
 to up trend 

Trend

Cohance Lifesciences is in  
Downtrendℹ
. 
Price of Cohance Lifesciences is  
Downℹ
 by  

5.94

%. 
Target
Buy @ 

865.75

Sell @ 

914

Current @ 

875.7

Volume

The trade volumes of Cohance Lifesciences have become  
Deficientℹ
The volume trend for Cohance Lifesciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Cohance Lifesciences is  

Down

 by  

80.88

% 

Valuation

The current market price of Cohance Lifesciences is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3031cr and total assets worth ₹ 3031cr, the balance sheet of Cohance Lifesciences is:  
Balancedℹ
. 
Cashflow
Cohance Lifesciences has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 38cr

. It is  
Upℹ
 by  

323.53

%. 

(*Mar 2025)

52.65% i.e. ₹ 288cr earned in operatingℹ
46.62% i.e. ₹ 255cr spent in investingℹ
0.55% i.e. ₹ 3cr earned in financingℹ
0.18% i.e. ₹ 1cr earned in otherℹ
Cohance Lifesciences has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 17cr

. It is  
Downℹ
 by  

185

%. 

(*Mar 2024)

48.84% i.e. ₹ 358cr earned in operatingℹ
49.39% i.e. ₹ 362cr spent in investingℹ
1.77% i.e. ₹ 13cr spent in financingℹ
0% in otherℹ
Income
The income of Cohance Lifesciences is  

₹ 563cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Cohance Lifesciences Profit is up by:  

21.05

% and Income is Up by:  

36.65

% 

(*Jun 2025)

The income of Cohance Lifesciences is  

₹ 412cr

 and  

Profit

 is :  

₹ 38cr

(*Mar 2025)

Cohance Lifesciences Profit is down by:  

54.22

% and Income is Up by:  

27.95

% 

(*Mar 2025)

The income of Cohance Lifesciences is  

₹ 322cr

 and  

Profit

 is :  

₹ 83cr

(*Dec 2024)

Cohance Lifesciences Profit is up by:  

2.47

% and Income is Up by:  

18.82

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.